Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF OCTOBER 23, 2021 SAM #7266
MODIFICATION

Q -- CLASS J&A TO ADD MONOCLONAL ANTIBODY INJECTIONS TO THE FEMA NATIONAL COVID-19 VACCINATION CONTRACT

Notice Date
10/21/2021 7:17:39 AM
 
Notice Type
Justification
 
NAICS
541990 — All Other Professional, Scientific, and Technical Services
 
Contracting Office
COMMUNITY SURVIVOR ASSISTANCE SEC WASHINGTON DC 20472 USA
 
ZIP Code
20472
 
Solicitation Number
70FB8022R00000003
 
Archive Date
11/20/2021
 
Point of Contact
Sharon Edwards, Erich Ducote
 
E-Mail Address
sharon.edwards3@fema.dhs.gov, erich.ducote@fema.dhs.gov
(sharon.edwards3@fema.dhs.gov, erich.ducote@fema.dhs.gov)
 
Award Number
70FB8021D00000002
 
Award Date
08/25/2211
 
Description
This is a class justification & approval (J&A) for the Department of Homeland Security, Federal Emergency Management Agency (FEMA) in accordance with (a) FAR 6.303-1(d) and 6.302-2, Unusual and Compelling Urgency. This J&A is related to solicitation # 70FB8021R00000001 - Medical Personnel for COVID-19 Vaccination Support This class J&A applies to the following IDIQ contracts: OptumServe Health Services, Inc., 328 Front Street South,�La Crosse, WI 546014 (Contract # 70FB8021D00000002)��and�AMN Health Inc.,�12400 High Bluff Dr,�San Diego, CA 92130 (Contract# 70FB8021D00000003) Background: FEMA previously competed and awarded the National Clinical Vaccination (NCV) contract which was recently awarded on May 15, 2021.� The NCV staffing contract is uniquely postured to administer the mAb immunizations, providing these prophylactic injections to prevent mild and moderate COVID-19 cases from progressing to hospitalization.� This procedure is classified as a passive vaccination and given subcutaneously (by injection under the skin).� �All vaccinator labor categories identified in the Statement of Work are capable of administering the injections subject to individual state health department direction. The urgent and compelling need to alleviate suffering and stem the progression of COVID-19 warrant the use of this contract for mAb immunization See attached J&A for further details.
 
Web Link
SAM.gov Permalink
(https://beta.sam.gov/opp/a1b4263f1ed04130af9851ee690ab87d/view)
 
Place of Performance
Address: USA
Country: USA
 
Record
SN06161850-F 20211023/211021230118 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.